Thalidomid-Analoga als Tnf-Alpha-Modulatoren
Anmelder: The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, P2D, Inc., THE GOVERNMENT OF UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP1663223
- Aktenzeichen
- EP04784385
- Anmeldetag
- 17. September 2004
- Veröffentlichung
- 1. Januar 2014
- Erteilung
- 1. Januar 2014
- Rechtsraum
- EP
- IPC
- A61K31/454
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services
P2D, Inc.
THE GOVERNMENT OF UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES - Land
- 🇺🇸 USA
Der Anmelder ist die US-Regierung, vertreten durch das Gesundheitsministerium, unter dessen Dach unter anderem die National Institutes of Health forschen. Das Patentportfolio konzentriert sich auf Medizintechnik, Pharma- und Biotechnologie sowie auf organische Chemie und Messtechnik. Anmeldungen stammen aus dem Zeitraum 2000 bis 2016.
441 Patente in unserer Datenbank
Fachgebiete
-
Couchman, Jonathan Hugh
NoneLeeds